Cargando…
Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis
Early lung inflammation has been implicated in the pathogenesis of bronchopulmonary dysplasia (BPD). We aimed to establish the efficacy and safety of systemic hydrocortisone for the prevention of BPD. A systematic review and meta-analysis were undertaken, with a detailed electronic literature search...
Autores principales: | Morris, Ian Paul, Goel, Nitin, Chakraborty, Mallinath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647381/ https://www.ncbi.nlm.nih.gov/pubmed/31144162 http://dx.doi.org/10.1007/s00431-019-03398-5 |
Ejemplares similares
-
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
por: Onland, Wes, et al.
Publicado: (2018) -
Hydrocortisone and bronchopulmonary dysplasia: variables associated with response in premature infants
por: Clauss, Christie, et al.
Publicado: (2020) -
Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial
por: He, Yuan, et al.
Publicado: (2020) -
Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
por: Onland, Wes, et al.
Publicado: (2011) -
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)